1. Home
  2. HY vs AURA Comparison

HY vs AURA Comparison

Compare HY & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyster-Yale Materials Handling Inc.

HY

Hyster-Yale Materials Handling Inc.

SELL

Current Price

$32.10

Market Cap

555.3M

Sector

Industrials

ML Signal

SELL

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

SELL

Current Price

$6.61

Market Cap

631.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HY
AURA
Founded
1991
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.3M
631.6M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
HY
AURA
Price
$32.10
$6.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
★ $50.00
$16.60
AVG Volume (30 Days)
123.4K
★ 950.8K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
★ 4.51%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,769,300,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.84
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$26.41
$4.73
52 Week High
$41.30
$9.54

Technical Indicators

Market Signals
Indicator
HY
AURA
Relative Strength Index (RSI) 45.42 51.08
Support Level $31.65 $6.03
Resistance Level $34.83 $7.83
Average True Range (ATR) 1.37 0.27
MACD 0.12 0.09
Stochastic Oscillator 68.70 88.00

Price Performance

Historical Comparison
HY
AURA

About HY Hyster-Yale Materials Handling Inc.

Hyster Yale Inc designs, engineers, manufactures, sells, and services a comprehensive line of lift trucks, attachments, aftermarket parts, and technology solutions marketed globally under the Hyster and Yale brand names. The company has four segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni). The majority of its revenue is generated from Lift Trucks. Geographically, it operates in America, EMEA, and JAPIC regions, of which maximum revenue is generated from its business in America, which includes lift truck operations in the U.S., Canada, Mexico, Brazil, and Latin America.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: